22 results
8-K
FGEN
FibroGen Inc
1 Dec 20
Departure of Directors or Certain Officers
8:05am
Eisner, M.D., M.P.H. as Incoming Chief Medical Officer, where he will oversee global clinical development and regulatory initiatives for FibroGen. K
S-1/A
EX-10.18
FGEN
FibroGen Inc
20 Oct 14
IPO registration (amended)
12:00am
Committee.
(a) Purpose; Formation. The Parties hereby establish a joint steering committee (the “JSC”) that will monitor and oversee their activities under … and providing a forum to discuss and coordinate the Parties’ activities under this Agreement, the JSC shall in particular:
(i) oversee the collaborative
S-1
EX-10.11
7tysgkpm
1 Oct 14
IPO registration
12:00am
DRS/A
EX-10
7jjxg
24 Sep 14
Draft registration statement (amended)
12:00am
S-1
EX-10.12
2v5bz4j 2x
1 Oct 14
IPO registration
12:00am
DRS/A
EX-10
5qdcmf1zu1yl4g6x3
24 Sep 14
Draft registration statement (amended)
12:00am
S-1
EX-10.28
jr0xb6w1w77
1 Oct 14
IPO registration
12:00am
DRS/A
EX-10
84zd1v76ws dpsbhd
24 Sep 14
Draft registration statement (amended)
12:00am